The medical dermatological market in the UK is worth £2bn and growing 10% annually. Demand is high, but we hear stretched NHS resources have been reducing supply. Earlier in the year, the NHS announced it would stop funding some procedures including the removal of benign skin lesions, and waiting lists for dermatological treatments are growing. We speak to a UK-based PE firm about resulting growth in the UK private dermatological market.
November 15, 2018
